Cargando…

A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80

PURPOSE: Recent studies have suggested the significant relationship between follicle-stimulating hormone (FSH) and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. However, it is unknown whether FSH impacts the risk of NAFLD in men. This study aimed to investigate the association b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yunxia, Xu, Jun, Zhang, Xiaoyan, Ke, Yingying, Fu, Guoxiang, Guo, Qihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507128/
https://www.ncbi.nlm.nih.gov/pubmed/34641807
http://dx.doi.org/10.1186/s12877-021-02490-6
_version_ 1784581790396055552
author Zhu, Yunxia
Xu, Jun
Zhang, Xiaoyan
Ke, Yingying
Fu, Guoxiang
Guo, Qihao
author_facet Zhu, Yunxia
Xu, Jun
Zhang, Xiaoyan
Ke, Yingying
Fu, Guoxiang
Guo, Qihao
author_sort Zhu, Yunxia
collection PubMed
description PURPOSE: Recent studies have suggested the significant relationship between follicle-stimulating hormone (FSH) and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. However, it is unknown whether FSH impacts the risk of NAFLD in men. This study aimed to investigate the association between serum FSH levels and NAFLD in elderly Chinese men aged 80–98, a particular group with worse outcomes of NAFLD. PATIENTS AND METHODS: A cross-sectional analysis was performed in 444 subjects in a geriatric health center. The highest quartile of serum FSH was used as reference. Hepatic steatosis was defined according to the results of liver ultrasound. Fibrosis-4 (FIB-4) Index > 2.67 was defined as advanced fibrosis. RESULTS: Based on liver ultrasound, 108 (24.3%) subjects had NAFLD. FSH level were negatively correlated with total testosterone, estradiol, nutritional risk, and the prevalence of high education level (all P < 0.01), and positively correlated with age, luteinizing hormone, alanine aminotransferase and aspartate aminotransferase (all P < 0.05). The correlation between FSH and body mass index or antihypertensive drug usage was marginally significant (P = 0.057; P = 0.066, respectively). The percentage of subjects with NAFLD had a trend to increase following the quartiles of serum FSH (20.0% in quartile 1, 18.2% in quartile 2, 27.3% in quartile 3, and 31.6% in quartile 4). After adjustment for common pathogenic risk factors, nutritional risk, and other sex hormones, serum FSH were progressively associated with odds ratios for NAFLD. The adjusted odds ratios and 95% CIs for quartile 1, quartile 2, and quartile 3, compared with quartile 4 were 0.132 (0.034–0.516), 0.190 (0.052–0.702), and 0.404 (0.139–1.173), respectively. Obesity was not involved in the potential negative role of circulating FSH on the risk of NAFLD in our population. Furthermore, our results revealed no significant association between FSH and advance fibrosis, the OR (95% CI) for advanced fibrosis was 1.018 (0.983–1.054) (P = 0.316) after adjusting for the potential covariates, although a positive correlation of FSH and FIB-4 score was observed (r = 0.325, P = 0.001). CONCLUSION: Low FSH level may decrease the risk of NAFLD in elderly Chinese men. These findings warrant replication in more extensive studies.
format Online
Article
Text
id pubmed-8507128
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85071282021-10-25 A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80 Zhu, Yunxia Xu, Jun Zhang, Xiaoyan Ke, Yingying Fu, Guoxiang Guo, Qihao BMC Geriatr Research PURPOSE: Recent studies have suggested the significant relationship between follicle-stimulating hormone (FSH) and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. However, it is unknown whether FSH impacts the risk of NAFLD in men. This study aimed to investigate the association between serum FSH levels and NAFLD in elderly Chinese men aged 80–98, a particular group with worse outcomes of NAFLD. PATIENTS AND METHODS: A cross-sectional analysis was performed in 444 subjects in a geriatric health center. The highest quartile of serum FSH was used as reference. Hepatic steatosis was defined according to the results of liver ultrasound. Fibrosis-4 (FIB-4) Index > 2.67 was defined as advanced fibrosis. RESULTS: Based on liver ultrasound, 108 (24.3%) subjects had NAFLD. FSH level were negatively correlated with total testosterone, estradiol, nutritional risk, and the prevalence of high education level (all P < 0.01), and positively correlated with age, luteinizing hormone, alanine aminotransferase and aspartate aminotransferase (all P < 0.05). The correlation between FSH and body mass index or antihypertensive drug usage was marginally significant (P = 0.057; P = 0.066, respectively). The percentage of subjects with NAFLD had a trend to increase following the quartiles of serum FSH (20.0% in quartile 1, 18.2% in quartile 2, 27.3% in quartile 3, and 31.6% in quartile 4). After adjustment for common pathogenic risk factors, nutritional risk, and other sex hormones, serum FSH were progressively associated with odds ratios for NAFLD. The adjusted odds ratios and 95% CIs for quartile 1, quartile 2, and quartile 3, compared with quartile 4 were 0.132 (0.034–0.516), 0.190 (0.052–0.702), and 0.404 (0.139–1.173), respectively. Obesity was not involved in the potential negative role of circulating FSH on the risk of NAFLD in our population. Furthermore, our results revealed no significant association between FSH and advance fibrosis, the OR (95% CI) for advanced fibrosis was 1.018 (0.983–1.054) (P = 0.316) after adjusting for the potential covariates, although a positive correlation of FSH and FIB-4 score was observed (r = 0.325, P = 0.001). CONCLUSION: Low FSH level may decrease the risk of NAFLD in elderly Chinese men. These findings warrant replication in more extensive studies. BioMed Central 2021-10-12 /pmc/articles/PMC8507128/ /pubmed/34641807 http://dx.doi.org/10.1186/s12877-021-02490-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Yunxia
Xu, Jun
Zhang, Xiaoyan
Ke, Yingying
Fu, Guoxiang
Guo, Qihao
A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title_full A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title_fullStr A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title_full_unstemmed A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title_short A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
title_sort low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507128/
https://www.ncbi.nlm.nih.gov/pubmed/34641807
http://dx.doi.org/10.1186/s12877-021-02490-6
work_keys_str_mv AT zhuyunxia alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT xujun alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT zhangxiaoyan alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT keyingying alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT fuguoxiang alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT guoqihao alowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT zhuyunxia lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT xujun lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT zhangxiaoyan lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT keyingying lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT fuguoxiang lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80
AT guoqihao lowfolliclestimulatinghormonelevelisaprotectivefactorfornonalcoholicfattyliverdiseaseinoldermenagedover80